S&P 500 Financials Sector SEC Filings — April 02, 2026

02-04-2026

Suncrete, Inc. (PubCo) entered into a Securities Exchange Agreement on March 26, 2026, to issue 26,000 shares of Series A Convertible Perpetual Preferred Stock (9.0% dividend, $1,000 liquidation preference per share) in exchange for Suncrete's Senior Preferred Units, conditional on Available Cash below $250.0 million prior to the Business Combination closing. The PIPE Investment commitment increased from $105.5 million to $167.1 million following a new $61.6 million subscription agreement on March 27, 2026. Haymaker postponed its Warrantholder and Shareholder Meetings to April 2, 2026, extending the redemption request deadline to April 1, 2026.

• ·Exchange occurs automatically prior to Acquisition Merger closing, post-acceptance of Certificate of Designation.
• ·Series A Preferred convertible at greater of $18.00 per share or 5-day VWAP of PubCo Class A Common Stock.
• ·PubCo may redeem Series A Preferred at liquidation preference plus accrued dividends.
• ·Securities issued under Section 4(a)(2) and/or Regulation D exemptions.

02-04-2026

Sylvamo Corporation (SLVM) issued a DEFA14A filing providing notice of proxy materials availability for its Annual Meeting of Shareholders on May 15, 2026, for shareholders of record as of March 20, 2026. The Board recommends voting FOR Proposal 1 (election of seven director nominees), Proposal 2 (ratification of Deloitte & Touche LLP as independent auditors for 2026), and Proposal 3 (non-binding advisory approval of named executive officer compensation). No financial metrics or performance data are disclosed in this notice.

• ·Shareholders of record as of March 20, 2026
• ·Proxy materials available via www.investorelections.com/SLVM, phone 1-866-648-8133, or email paper@investorelections.com (using 12-digit control number)
• ·Board of Directors unanimously recommends FOR on all three proposals

02-04-2026

Pharming Group N.V. reported record annual revenues of $376,134 thousand for the year ended December 31, 2025, up 26.6% YoY from $297,200 thousand in 2024, driven by RUCONEST® (+26.0% to $317,921 thousand) and Joenja® (+29.5% to $58,213 thousand), mainly from U.S. sales. The company swung to an operating profit of $25,842 thousand from a $8,621 thousand loss, with gross profit up 26.3% to $330,634 thousand at stable ~88% margins; however, operating expenses rose 14.2% to $311,320 thousand, finance net costs deteriorated to a $13,618 thousand loss from a $1,889 thousand gain, and net profit was modest at $2,538 thousand versus a $11,841 thousand loss. Basic EPS improved to $0.004 from -$0.018.

• ·U.S. revenues: $361,746 thousand (2025) vs $287,149 thousand (2024), 96% of total
• ·Europe and RoW revenues: $14,388 thousand (2025) vs $10,051 thousand (2024)
• ·Cost of inventories: $31,972 thousand (2025) vs $25,645 thousand (2024)
• ·Royalty fees: $5,793 thousand (2025) vs $4,907 thousand (2024)
• ·Sales milestone: $5,000 thousand (2025)
• ·Obsolete inventory impairments: $2,735 thousand (2025) vs $4,847 thousand (2024, decline)
• ·Basic EPS: $0.004 (2025) vs -$0.018 (2024)
• ·Filing date: April 02, 2026 for year ended December 31, 2025

02-04-2026

BK Technologies Corporation announced an investor conference on April 2, 2026, at 9:00 a.m. Eastern Time, with presentation materials furnished as Exhibit 99.1 under Item 7.01. The filing includes forward-looking statements regarding product groups, new products like the BKR Series, capital allocation, and potential acquisitions, along with non-GAAP financial measures. No specific financial results or period-over-period comparisons are disclosed in the filing text.

02-04-2026

Largo Inc. filed Amendment No. 1 to its Form 40-F Annual Report for the fiscal year ended December 31, 2025, to correct an inadvertently incorrect version of Exhibit 99.3 (Management's Discussion and Analysis). No changes were made to the audited financial statements or other information from the original filing dated April 1, 2026. As of December 31, 2025, the company had 83,673,905 common shares outstanding and confirmed its status as an emerging growth company.

• ·Auditor: KPMG LLP (PCAOB ID: 85), Toronto, Ontario, Canada
• ·Original filing date: April 1, 2026
• ·Amendment signature date: April 1, 2026
• ·Emerging growth company: Yes
• ·New certifications filed by Co-Chief Executive Officers and Chief Financial Officer

02-04-2026

Hyatt Hotels Corporation's DEF 14A proxy statement for the 2026 Annual Meeting on May 20, 2026, seeks stockholder approval for the election of three Class II directors (Gianni Marostica, Heidi O’Neill, and Richard C. Tuttle) amid Thomas J. Pritzker's departure, reducing the Board from 12 to 11 members. The Board recommends voting FOR the ratification of Deloitte & Touche LLP as independent auditors and advisory approval of named executive officer compensation, but AGAINST a stockholder proposal. No financial performance metrics are highlighted, with emphasis on governance features like pay-for-performance compensation and World of Care initiative.

• ·Record date for Annual Meeting: March 23, 2026
• ·Annual Meeting held online via live webcast at 9:30 a.m. Central Time; pre-registration required at www.proxydocs.com/h
• ·Proxy materials and Annual Report for fiscal year ended December 31, 2025 available at www.proxydocs.com/h
• ·Key governance features: pay-for-performance, no hedging, share ownership requirements, no single-trigger change-in-control provisions

02-04-2026

Kodiak Gas Services, Inc. (NYSE: KGS) completed the acquisition of Distributed Power Solutions, LLC (DPS) on April 1, 2026, for $587 million in cash and approximately 2.4 million shares of common stock, adding 395 megawatts of generation capacity and expanding into distributed power solutions for data centers, microgrids, manufacturing, and energy infrastructure. The acquisition is expected to be immediately accretive to earnings and discretionary cash flow per share, while extending contracted cash flows. No negative financial impacts or declines were reported.

• ·DPS rebranded as Kodiak Power Solutions, a division of Kodiak Gas Services.
• ·Integration activities underway focusing on service continuity, operational excellence, and safety.
• ·Headquartered in The Woodlands, Texas.

02-04-2026

On April 1, 2026, Clearway Energy, Inc., Clearway Energy LLC, and Clearway Energy Group LLC entered into a Third Amended and Restated Exchange Agreement, amending the prior agreement dated October 28, 2024. The amendment changes the exchange provision so that CEG Unitholders may now exchange Class B units of Clearway Energy LLC for shares of Class C common stock (previously Class A common stock) on a one-for-one basis, with corresponding Class B common stock shares extinguished upon exchange. No financial terms or impacts are disclosed in the filing.

• ·Exchange remains subject to equitable adjustments for stock splits, stock dividends, and reclassifications.
• ·Agreement filed as Exhibit 10.1.

02-04-2026

On April 1, 2026, Clearway Energy LLC, Clearway Energy, Inc., and Clearway Energy Group LLC entered into a Third Amended and Restated Exchange Agreement, amending the prior Second Amended Exchange Agreement dated October 28, 2024. The amendment changes the exchange terms, allowing CEG Unitholders to exchange Class B units of Clearway Energy LLC for shares of Class C common stock of Clearway Energy, Inc. (instead of Class A common stock) on a one-for-one basis, subject to equitable adjustments, with corresponding extinguishment of Class B common stock shares. The full agreement is attached as Exhibit 10.1.

• ·Agreement amends and restates the Second Amended Exchange Agreement dated October 28, 2024.
• ·Exchanges remain on a one-for-one basis, subject to equitable adjustments for stock splits, stock dividends, and reclassifications.
• ·Filing date: April 2, 2026; Date of earliest event: April 1, 2026.

02-04-2026

News Corporation filed an 8-K on April 2, 2026, disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock, as required under ASX rules. Exhibits 99.1 and 99.2 contain the specific ASX disclosures dated as noted therein. The filing includes forward-looking statements on potential repurchases, subject to market conditions and other factors.

• ·Event date (earliest reported): April 1, 2026
• ·Securities registered: Class A Common Stock (NWSA, par value $0.01/share, Nasdaq Global Select Market); Class B Common Stock (NWS, par value $0.01/share, Nasdaq Global Select Market)

02-04-2026

Terra Property Trust, Inc. completed its exchange offers on March 30, 2026, exchanging $24,027,025 of 6.00% unsecured Senior Notes due June 30, 2026, and $1,550,975 of 7.00% unsecured Senior Notes due March 31, 2026 issued by subsidiary TIF6, for $25,578,000 aggregate principal of new 7.00% Senior Secured Notes due March 31, 2029, secured by equity interests in 18 subsidiaries. The new notes carry a 7% interest rate payable monthly starting April 30, 2026, with covenants limiting additional debt and dividends unless a Collateral Coverage Ratio of at least 1.35:1.00 is maintained; no subsidiary guarantees were provided as of issuance.

• ·Exchange Offers expired March 26, 2026, with final settlement on March 30, 2026; TIF6 repaid remaining TIF6 Notes principal on March 31, 2026.
• ·Exchange Notes redeemable at 101% prior to December 31, 2026, and 100% thereafter, plus accrued interest.
• ·Indenture filed as Exhibit 4.1; no requirement to offer purchase on change of control.

02-04-2026

Dynaresource, Inc. (DYNR) filed an 8-K on April 2, 2026, under Item 9.01, attaching Exhibit 99.1, a press release issued on April 1, 2026, related to an event on the same date. The filing contains no financial statements, quantitative metrics, or operational updates within the form itself. It was signed by CEO Rohan Hazelton.

02-04-2026

SecureTech Innovations, Inc. (OTCQB: SCTH) nominated Brian Zucker, CPA, age 64, a securities industry veteran with over 30 years of experience, to serve as an independent director and member of the Audit, Compensation, and Nomination Committees, effective upon NASDAQ Capital Market listing approval and obtaining satisfactory D&O insurance. The nomination is part of broader efforts to strengthen corporate governance ahead of uplisting, with two additional director nominees planned. CEO J. Scott Sitra highlighted Zucker's expertise in financial oversight and public company governance.

• ·Nomination announced March 31, 2026; not effective until NASDAQ listing and D&O insurance obtained.
• ·Mr. Zucker: CPA licensed in NY/NJ; FINRA Series 7, 24, 27, 53, 63, 79, 99; BS Public Accounting from Pace University; AICPA member.
• ·No related party transactions, family relationships, or compensatory arrangements with Mr. Zucker yet.
• ·Press release furnished as Exhibit 99.1 under Regulation FD Disclosure.

02-04-2026

Venu Holding Corporation reported total assets of $370.5 million as of December 31, 2025, up 108% or $192.1 million from $178.4 million at year-end 2024, driven by property and equipment growth to $305.9 million (up 123% from $137.2 million). Luxe FireSuiteTM and Aikman Club sales reached a record $126.1 million for the full year, up 62% YoY from $77.7 million, with the new triple net leaseback model comprising 25% of those sales. However, total revenue was nearly flat at $17.9 million compared to $17.8 million in 2024.

• ·Structural steel erected at Sunset Amphitheater McKinney (20,000 seats) and Broken Arrow (12,500 seats), with Broken Arrow canopy roof completed post-year end, targeting Fall 2026 opening.
• ·Entered LOI for multi-season entertainment destination in Webster, Texas (Houston MSA).
• ·Land acquisition for 12,500-seat Sunset Amphitheater El Paso with city partnership.
• ·$86.25 million capital raise in March 2026 during market volatility.
• ·Appraisal of $1.24 billion is as-completed value using cost, income, and sales approaches; differs from GAAP cost basis.

02-04-2026

Mannatech, Incorporated filed an 8-K announcing a Form 12b-25 Notification of Late Filing for its Form 10-K for the fiscal year ended December 31, 2025, due to its independent auditor raising a potential going concern issue, necessitating additional time for management assessment, third-party tax advisor discussions, and review of a cost-reduction plan. The company was unable to meet the original March 31, 2026 deadline without unreasonable effort or expense. It expects to file the 10-K within the 15-day extension period, by April 15, 2026.

• ·Form 10-K covers fiscal year ended December 31, 2025.
• ·Original 10-K due date: March 31, 2026.
• ·Principal executive offices: 1410 Lakeside Parkway, Suite 200, Flower Mound, TX 75028.
• ·NASDAQ trading symbol: MTEX.

02-04-2026

CareView Communications, Inc., along with its subsidiary Borrower, PDL Investment Holdings, LLC as Lender, Steven G. Johnson (President and CEO), and Dr. James R. Higgins (director), entered into the Fourteenth Amendment to the Credit Agreement on March 30, 2026, extending the Maturity Date to June 30, 2026. This amendment continues a long series of prior modifications to the original June 26, 2015 Credit Agreement and related Modification Agreement, with dozens of amendments listed dating back to 2015. The update creates or modifies a direct financial obligation under Item 2.03.

• ·Original Credit Agreement dated June 26, 2015
• ·Filing incorporates 30+ prior amendments to Credit Agreement and Modification Agreement as exhibits, with latest prior ones in December 2025

02-04-2026

Crown Reserve Acquisition Corp. I announced a definitive Business Combination Agreement with Carvix, Inc., valuing Carvix at a $1.0 billion implied enterprise value in an all-stock transaction, with Crown Reserve domesticate to Delaware prior to closing and the combined company to trade on Nasdaq. The deal includes commitments for at least $80.0 million in PIPE financing, a $20.0 million equity line of credit, and a minimum $10.0 million cash at closing after redemptions and expenses. Earnout provisions provide up to 50,000,100 additional shares for Carvix stockholders and 3,000,000 for the Sponsor, tied to revenue and EBITDA targets starting January 1, 2027.

• ·Post-closing board: five members (four nominated by Carvix including one independent, one by Sponsor who is independent).
• ·Carvix management team to continue leading post-closing.
• ·Lock-up agreements: 18 months for directors/officers; Sponsor lock-up earlier of six months post-PIPE or 18 months post-closing.
• ·Transaction intended as tax-free reorganization under IRC Sections 368(a)(1)(F) and 368(a).
• ·Closing conditions include shareholder approvals, S-4 effectiveness, Nasdaq listing, minimum cash, no material adverse effect; terminable if not closed by September 30, 2026.

02-04-2026

Lion Copper and Gold Corp. reported consolidated net income of $4,383 thousand for the year ended December 31, 2025, versus a $4,741 thousand loss in 2024, primarily due to a $26,381 thousand gain on deconsolidation of Falcon Copper Corp. However, operating loss widened significantly to $16,660 thousand from $3,814 thousand, driven by higher general and administrative expenses ($10,066 thousand vs $5,014 thousand) and share-based compensation ($8,772 thousand vs $1,523 thousand). Total assets increased to $29,468 thousand from $17,140 thousand, but cash and cash equivalents declined to $2,364 thousand from $7,999 thousand, with negative operating cash flow of $13,166 thousand versus positive $3,942 thousand.

• ·Investment in associate increased to $17,829 thousand from $1,102 thousand.
• ·Derivative liabilities rose to $3,564 thousand from $289 thousand.
• ·Shares issued for option and warrant exercises: 2,223,635 in 2025.
• ·Cash used in investing activities: $28,719 thousand in 2025, mainly due to $24,090 thousand cash lost upon deconsolidation and $2,995 thousand acquisition of Butte Valley.

02-04-2026

Algorhythm Holdings, Inc. (RIME) filed its 10-K on April 02, 2026, highlighting a history of losses and substantial doubt about its ability to continue as a going concern, as stated in the audit report by M&K CPAs, PLLC for the year ended December 31, 2025. The filing details extensive risks including the need for additional capital, material weaknesses in internal controls over financial reporting, dependence on market acceptance of its SemiCab technology platform, cyber threats, geopolitical tensions, and potential Nasdaq delisting. No positive financial performance metrics were provided, with ongoing challenges from prior Singing Machine business sale and operational strains.

• ·Company identified material weaknesses in internal control over financial reporting during assessment for audited consolidated financial statements.
• ·Risks include potential Nasdaq delisting if continued listing requirements not met.
• ·Never paid dividends on common stock and does not intend to in foreseeable future.

02-04-2026

For the six months ended December 31, 2025, FreeCast's total revenue declined 4% YoY to $257,950 from $269,952, with three-month revenue dropping sharply 59% to $62,090 from $151,545; however, gross profit more than doubled, rising 77% to $166,209 due to a 48% reduction in cost of revenue. Operating expenses fell 24% to $5,723,644, narrowing the six-month net loss to $5,646,331 (25% improvement) from $7,489,323 YoY, and cash burn from operations improved to $5.2M used from $6.7M. Balance sheet shows total assets down 11% to $1.23M, cash at $433,363 (21% below June 30, 2025), but liabilities decreased 23% to $4.78M and stockholders' deficit improved to $3.55M.

• ·Convertible Note Payable - Related Party current liability: $2,425,552 at Dec 31, 2025 (down from $3,865,555 at June 30, 2025)
• ·Series A Preferred Stock: 4,000,000 shares issued and outstanding as of Dec 31, 2025
• ·Net cash used in operating activities improved 22% YoY to $5,232,882 for six months
• ·Proceeds from Class A common stock - related party: $2,700,000 in financing activities six months

02-04-2026

VITASPRING BIOMEDICAL CO. LTD. reported no revenues for Q1 FY2025, resulting in a net loss of $216,831, improved from $304,601 in Q1 FY2024 due to lower SG&A expenses (down 28.8% YoY). However, total assets declined 4.4% QoQ to $131,288, cash burn from operations improved to only $4,023 (vs. $27,940 YoY), but stockholders' deficit worsened to $(3,525,803) amid rising liabilities.

• ·Equipment and vehicle, net declined to $21,574 from $24,063 QoQ.
• ·Operating lease right-of-use asset decreased to $45,407 from $89,652 QoQ.
• ·Stock-based compensation expense of $41,217 in Q1 FY2025, similar to $41,216 in prior year.
• ·Accounts receivable net at $0 with full allowance of $33,632.

02-04-2026

For the three months ended February 28, 2026, FactSet revenues grew 7% YoY to $611M, but operating income was slightly down 0.3% to $185M and net income declined 8% to $133M amid higher cost of services and SG&A expenses. Over six months, revenues rose 7% YoY to $1.22B with operating income flat at $377M and net income down 3% to $286M; however, operating cash flow surged 28% to $333M, funding $303M in share repurchases.

• ·Cash and cash equivalents decreased to $268M from $338M at August 31, 2025.
• ·Total assets declined to $4.22B from $4.30B at August 31, 2025.
• ·Long-term debt stable at approximately $1.37B.
• ·No acquisitions in six months ended February 28, 2026 (vs $342M in prior year).
• ·Dividends declared $81M for six months ended February 28, 2026.

02-04-2026

Global Net Lease, Inc. (GNL) announced that board members Sue Perrotty and Governor Edward Rendell will retire effective immediately following the 2026 Annual Meeting of Stockholders and will not stand for re-election. They provided 11 and 14 years of service, respectively, including leadership through the 2023 merger and internalization. Post-meeting, the Board will consist of eight members if all nominees are elected.

• ·GNL is a publicly traded internally managed REIT (NYSE: GNL) focused on net lease assets in the U.S., Western and Northern Europe.
• ·Investor Relations contact: investorrelations@globalnetlease.com or (323) 265-2020.

02-04-2026

Inovio Pharmaceuticals, Inc. notified Oppenheimer & Co. Inc. on April 1, 2026, that it is suspending and terminating the August 13, 2024 ATM Prospectus under the Sales Agreement, halting any further sales of common stock until a new prospectus is filed. As of that date, the company had issued and sold 1,319,644 shares for aggregate gross proceeds of $3.2 million before commissions and expenses. The Sales Agreement remains in full force and effect.

• ·Sales Agreement originally filed as Exhibit 1.1 to 8-K on August 13, 2024
• ·Prospectus dated August 13, 2024

02-04-2026

Cohu Inc.'s DEF 14A proxy statement filed April 2, 2026, highlights FY2025 financials with sales of $453.0 million up 13% YoY and gross margins of 42.7% GAAP / 43.3% non-GAAP, bolstered by $484.0 million in cash & investments; however, the company reported a GAAP loss per diluted share of $(1.59) and non-GAAP EPS of $(0.22). Shareholders are voting on electing three Class 1 directors (William E. Bendush, Karen M. Rapp, Nina L. Richardson), say-on-pay approval, increasing authorized common shares from 90,000,000 to 150,000,000, approving the 2026 Equity Incentive Plan and amended 1997 ESPP, and ratifying Ernst & Young LLP as FY2026 auditors.

• ·Company founded in 1947 with headquarters in San Diego, CA.
• ·Proposal to amend Certificate of Incorporation to increase authorized common stock from 90,000,000 to 150,000,000 shares.
• ·Board recommends FOR all six proposals including director elections, say-on-pay, equity plans, and auditor ratification.

02-04-2026

Service Properties Trust amended its Declaration of Trust, effective March 30, 2026, to increase total authorized shares of beneficial interest from 300,000,000 to 1,000,000,000, with Common Shares rising from 200,000,000 to 900,000,000 (+350%) while Preferred Shares remain at 100,000,000 (flat). The aggregate par value for Preferred Shares increased from $2,000,000 to $9,000,000 (+350%). The amendment was approved solely by the Board of Trustees, with no shareholder approval required under Maryland REIT Law.

• ·Amendment filed as Exhibit 3.1 in 8-K on April 02, 2026, covering Items 1.01, 5.03, 9.01.
• ·Common Shares have $0.01 par value per share; Preferred Shares without par value.
• ·No shareholder approval required per Section 8-203(a)(8) of Maryland REIT Law and Article V, Section 5.1 of Declaration.

02-04-2026

Burford Capital Limited's DEF 14A proxy statement, filed April 2, 2026, invites shareholders to the 2026 AGM on May 13, 2026, to vote on re-electing six directors (Rukia Baruti Dames, Christopher Bogart, Pamela Corrie, Robert Gillespie, Christopher Halmy, John Sievwright), electing new director Rick Noel, declaring a final dividend of 6.25¢ per ordinary share payable June 12, 2026, reappointing KPMG LLP as auditor, advisory Say-on-Pay approval, receiving 2025 accounts, and authorizing share allotments, repurchases, and disapplication of pre-emption rights. No period-over-period financial performance data or compensation figures are provided in the filing excerpt. The resolutions include both ordinary (requiring simple majority) and special (75% majority) votes.

• ·2026 AGM location: Oak House, Hirzel Street, St. Peter Port, Guernsey GY1 2NP at 9:00 a.m. British Summer Time
• ·Record date for voting: March 16, 2026
• ·Dividend record date: May 22, 2026
• ·Advance registration to attend AGM required by May 7, 2026, 10:00 a.m. BST
• ·Notice and access delivery method used for proxy materials starting April 2, 2026

02-04-2026

Accendra Health, Inc., following the sale of its Products & Healthcare Services business and Owens & Minor brand on December 31, 2025, filed a definitive proxy statement on April 2, 2026, for its virtual Annual Meeting of Shareholders on May 14, 2026, at 9:00 a.m. ET. Key proposals include election of directors, ratification of the independent auditor, advisory approval of executive compensation, and approval of the Amended and Restated 2023 Omnibus Incentive Plan. Management highlights a focused strategy on home healthcare via Apria and Byram Healthcare brands, with optimism for growth amid aging populations and chronic care demand, supported by investments in technology and efficiency.

• ·Virtual Annual Meeting accessible via Internet; instructions on page 76.
• ·Proxy materials and 2025 Annual Report available online; paper copies available on request.
• ·Pay Versus Performance disclosure covers years 2021-2025 for PEO and Non-PEO NEOs, including equity awards granted, outstanding/unvested values, changes in fair value, and adjustments.

02-04-2026

Transocean Ltd. announced contract awards and extensions totaling approximately $1.0 billion in incremental firm contract backlog, including a 1,095-day contract for the Transocean Barents with Vår Energi ASA at $450,000 per day (~$490 million), a 1,095-day extension for the Deepwater Orion with Petrobras (~$420 million), and a 365-day extension for the Deepwater Aquila with Petrobras (~$160 million). The company also retired $358 million of 8.375% Senior Secured Notes due 2028, saving approximately $39 million in interest expense to maturity, and expects to retire a total of $0.75 billion of debt in 2026. However, prior to the extension periods, existing backlog for Deepwater Orion and Deepwater Aquila will be reduced by approximately $20 million and $10 million, respectively.

• ·Transocean Barents contract anticipated to commence mid-Q2 2027, with options potentially extending into 2034.
• ·Deepwater Orion extension commits rig through March 2030; gap period ~340 days from April 1, 2026.
• ·Deepwater Aquila extension commits rig through June 2028; gap period ~450 days from April 1, 2026.
• ·Titan Notes retired in full on March 20, 2026 using cash on hand and debt service reserve.

02-04-2026

AirSculpt Technologies reported fourth quarter FY2025 revenue of $33.4 million, down 14.6% YoY due to a 15.0% decline in case volume to 2,604, while full year revenue fell 15.8% to $151.8 million amid a 15.6% drop in cases to 11,852. However, Q4 adjusted EBITDA rose to $2.5 million from $1.9 million YoY and net loss narrowed to $1.3 million from $5.0 million, though full year adjusted EBITDA declined to $15.1 million from $21.0 million. For FY2026, the company guides revenue of $151-157 million and adjusted EBITDA of $15-17 million, with Q1 revenue expected at $38.5-39.5 million implying flat same-store revenue.

• ·Annual Meeting of Stockholders rescheduled to May 12, 2026.
• ·Q1 2026 revenue guidance: $38.5-39.5 million.
• ·Cash and cash equivalents: $8.4 million as of Dec 31, 2025; borrowing capacity: $5.0 million.
• ·Same-center Q4 FY2025 cases declined 18.5% YoY to 2,345.
• ·FY2025 net loss: $11.7 million vs. $8.0 million in FY2024.

02-04-2026

LightInTheBox Holding Co., Ltd. reported total revenues declining sharply from $629.4 million in 2023 to $255.3 million in 2024 (-59.5% YoY) and further to $224.3 million in 2025 (-12.2% YoY), driven by product sales dropping from $617.2 million to $215.8 million over the same periods. While gross margins improved with cost of revenues as a percentage of total revenues falling from 42.8% in 2023 to 35.0% in 2025, operating expenses remained high at around 61% of revenues, and the company highlighted ongoing risks including past net losses, negative operating cash flows, and potential restrictions on subsidiary dividends due to PRC regulations. The filing also details operational properties across Singapore, the US, and various PRC locations totaling approximately 43,265 square meters.

• ·Services and others revenues declined from $12.2M in 2023 to $8.5M in 2025.
• ·Fulfillment expenses as % of revenues stable at 7.4% in both 2024 and 2025.
• ·Selling and marketing expenses as % of revenues increased to 45.7% in 2025 from 43.8% in 2024.
• ·General and administrative expenses as % of revenues decreased to 8.7% in 2025 from 10.1% in 2024.
• ·Ongoing risks include reliance on PRC and Hong Kong subsidiaries for dividends, with potential government restrictions on fund transfers.

02-04-2026

ESAB Corporation announced the appointment of R. Brent Jones as Chief Financial Officer effective early May 2026, succeeding Kevin Johnson who is departing to pursue a CFO role at a privately held company, with Johnson assisting in the transition. Jones brings over three decades of experience, including prior CFO roles at Avantor and Pall Corporation. Despite recent geopolitical events, ESAB reaffirms its previously announced 2026 guidance ranges for total core sales, aEBITDA, and aEPS.

• ·ESAB founded in 1904, based in North Bethesda, Maryland, serves customers in approximately 150 countries
• ·Kevin Johnson's tenure at ESAB: past seven years

02-04-2026

Lindsay Corporation reported Q2 FY2026 revenues of $157.7 million, down 16% YoY from $187.1 million, driven by a 5% decline in irrigation to $141.2 million (North America -8%, International -1%) and a 58% drop in infrastructure to $16.5 million due to the absence of a prior $20 million Road Zipper project, though road safety products grew. Operating income fell 59% to $13.0 million with margins contracting to 8.3% from 17.2%, and net earnings decreased 55% to $12.0 million ($1.15 diluted EPS). Positives include progress on the $80 million MENA irrigation project (deliveries begun, ~$70 million expected this FY), backlog growth to $151.8 million from $127.0 million, and $25.2 million in share repurchases (YTD $55.5 million).

• ·Diluted EPS $1.15 vs $2.44 prior year (-53%)
• ·Q2 cash dividends declared per share $0.37 vs $0.36 prior year
• ·Backlog includes $19.2M not expected to fulfill within next 12 months (vs $11.9M prior year)
• ·Six months FY2026 revenues $313.5M vs $353.3M prior year
• ·Infrastructure backlog decreased YoY while irrigation backlog increased due to MENA project

02-04-2026

Flutter Entertainment plc announced that independent Director Alfred F. Hurley, Jr., who has served since June 2016, will retire after a ten-year term and not stand for re-election at the 2026 Annual General Meeting on May 29, 2026. John Bryant, Chair of the Board, thanked Hurley for his contributions, including during the U.S. listing transition and as Chair of the Compensation and Human Resources Committee. Effective post-AGM, Nancy Dubuc will replace Hurley as Chair of the Compensation and Human Resources Committee.

• ·Flutter notified the Board of Hurley's retirement decision.
• ·Enquiries: Edward Traynor, +353872232455

02-04-2026

Sally Beauty Holdings, Inc. (NYSE: SBH) appointed Adrianne Lee as Senior Vice President and Chief Financial Officer effective April 28, 2026, succeeding Marlo Cormier, who will depart effective April 11, 2026, to pursue other opportunities. Ms. Lee brings extensive finance leadership experience from Bed Bath & Beyond, The Hertz Corporation, and other firms. The Company reaffirmed its previously issued second quarter and fiscal year 2026 financial guidance.

• ·Adrianne Lee previously served as President and CFO at Bed Bath & Beyond, joining as CFO in 2020
• ·Guidance for Q2 and FY2026 originally provided on February 9, 2026
• ·Sally Beauty operates through Sally Beauty and Beauty Systems Group segments

02-04-2026

Oceaneering International Inc. (OII) filed a DEFA14A Definitive Additional Proxy Materials on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as soliciting material under § 240.14a-12 with no fee required. No substantive proxy details or financial data are provided in the filing header.

• ·Filed by the Registrant.
• ·Not a preliminary or confidential proxy statement.

02-04-2026

Pharvaris N.V. reported a net loss of €175,699,397 for the year ended December 31, 2025, a 31% increase YoY from €134,221,527, primarily due to R&D expenses rising 26% to €124,478,334 while total operating expenses grew 17% to €169,822,932. General and administrative expenses declined 4% to €45,344,598, providing a slight offset. Cash and cash equivalents ended at €291,678,888, up 4% from €280,728,037, bolstered by €160,607,219 in financing activities despite higher operating cash burn of €137,073,634 (up 14%).

• ·Basic and diluted loss per share: €(2.97) in 2025 vs €(2.48) in 2024.
• ·Accumulated loss: €579,596,307 as of Dec 31, 2025.
• ·Share premium increased to €792,549,401 from €623,641,380.

02-04-2026

Solstice Advanced Materials Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on May 22, 2026, at 10:30 a.m. EDT, held virtually at www.virtualshareholdermeeting.com/SOLS2026. Shareholders are voting on the election of four Class I director nominees—Peter Gibbons, Rose Lee, William Oplinger, and Patrick Ward—for a two-year term until the 2028 Annual Meeting, ratification of Deloitte & Touche LLP as the independent auditor for 2026, an advisory vote to approve executive compensation, and an advisory vote on the frequency of future say-on-pay votes (board recommends 1 year). Proxy materials, including the 2026 Notice, Proxy Statement, and 2025 Annual Report, are available online at www.ProxyVote.com, with paper copies requestable by May 8, 2026.

• ·Voting deadline: May 21, 2026, 11:59 p.m. EDT at www.ProxyVote.com
• ·Material request deadline: May 8, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
• ·Company address: 115 Tabor Road, Morris Plains, NJ 07950
• ·Proxies may vote on other matters at discretion

02-04-2026

JetBlue Airways Corp (JBLU) has issued a DEFA14A proxy card for its 2026 Annual Meeting of Stockholders on May 14, 2026, held virtually, where shareholders will vote on electing 13 director nominees, advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, and an amendment to the 2020 Crewmember Stock Purchase Plan to increase authorized shares. The Board recommends voting 'For' all proposals. No financial metrics or performance data are disclosed in this filing.

• ·Annual Meeting: May 14, 2026, 9:00 a.m. EDT, virtually at www.virtualshareholdermeeting.com/JBLU2026
• ·Request proxy materials by April 30, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
• ·Vote online at www.ProxyVote.com

02-04-2026

Roivant announced expansion of the brepocitinib program with a seamless Phase 2b/3 trial in lichen planopilaris (LPP), enrolling first subjects in March 2026 as the fourth late-stage indication alongside dermatomyositis (DM; PDUFA Q3 2026), non-infectious uveitis (NIU), and cutaneous sarcoidosis (CS). However, Immunovant’s two Phase 3 studies of batoclimab in thyroid eye disease (TED) failed to meet the primary endpoint of ≥2mm proptosis responder rate at Week 24, despite greater proptosis improvements during the initial high-dose period. Roivant will host an investor call on April 2, 2026, at 8:00 a.m. ET, and Immunovant plans to advance IMVT-1402, with Graves’ disease topline data expected in 2027.

• ·No FDA-approved therapies exist for LPP.
• ·FDA granted Priority Review to brepocitinib NDA for DM with PDUFA target action date in Q3 2026.
• ·Topline Phase 3 data in NIU expected in H2 2026.
• ·Phase 3 study initiation in CS expected in H2 2026.
• ·Topline data from IMVT-1402 studies in Graves’ disease expected in 2027.
• ·Safety results for batoclimab in TED consistent with previous findings, no new safety signals.